APA

Tseng P., Chen C., Hu K., Cheng H., Lin Y., Tsai W., Cheng T., Wu W., Yeh C., Lin C., Tsai H., Chang H., Chuang J., Shan Y. & Chang W. (2018). The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition. : Oncotarget.

Chicago

Tseng Po-Lin, Chen Chih-Wei, Hu Keng-Hsun, Cheng Hung-Chi, Lin Yuan-Ho, Tsai Wen-Hui, Cheng Tain-Junn, Wu Wei-Hsuan, Yeh Chin-Wei, Lin Chin-Chih, Tsai Hui-Ju, Chang Hao-Chun, Chuang Jiin-Haur, Shan Yan-Shen and Chang Wen-Tsan. 2018. The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition. : Oncotarget.

Harvard

Tseng P., Chen C., Hu K., Cheng H., Lin Y., Tsai W., Cheng T., Wu W., Yeh C., Lin C., Tsai H., Chang H., Chuang J., Shan Y. and Chang W. (2018). The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition. : Oncotarget.

MLA

Tseng Po-Lin, Chen Chih-Wei, Hu Keng-Hsun, Cheng Hung-Chi, Lin Yuan-Ho, Tsai Wen-Hui, Cheng Tain-Junn, Wu Wei-Hsuan, Yeh Chin-Wei, Lin Chin-Chih, Tsai Hui-Ju, Chang Hao-Chun, Chuang Jiin-Haur, Shan Yan-Shen and Chang Wen-Tsan. The decrease of glycolytic enzyme hexokinase 1 accelerates tumor malignancy via deregulating energy metabolism but sensitizes cancer cells to 2-deoxyglucose inhibition. : Oncotarget. 2018.